Buerger’s disease or thromboangiitis obliterans: description of two cases

Beyond Rheumatology 2019; 1 (2) : e260
DOI: 10.4081/br.2019.21

Catastrophic antiphospholipid syndrome: a narrative review

Beyond Rheumatology 2019; 1 (2) : e261
DOI: 10.4081/br.2019.23

Long-term outcomes in a cohort of patients with juvenile idiopathic arthritis: serological phenotypes and disease activity in adulthood

Beyond Rheumatology 2019; 1 (2) : e262
DOI: 10.4081/br.2019.25

Physiotherapy rehabilitation in patients with ankylosing spondylitis

Beyond Rheumatology 2019; 1 (2) : e264
DOI: 10.4081/br.2019.6

Nutritional aspects of bone health: Not only a matter of vitamin D

Beyond Rheumatology 2019; 1 (1) : e254
DOI: 10.4081/br.2019.2

Biosimilars: New guns for the treatment of rheumatological patients?

Beyond Rheumatology 2019; 1 (1) : e255
DOI: 10.4081/br.2019.3

The journey of canakinumab; on- and off-label indications

Beyond Rheumatology 2019; 1 (1) : e256
DOI: 10.4081/br.2019.4

Beyond Rheumatology. A new challenge devoted to the advancement of knowledge in all rheumatology-related fields

Beyond Rheumatology 2019; 1 (1) : e257
DOI: 10.4081/br.2019.5

Transthoracic ultrasound versus intraoperative ultrasound in patients with pulmonary fibrosis: Reappraisal of artifacts

Beyond Rheumatology 2019; 1 (1) : e258
DOI: 10.4081/br.2019.7

Kidney involvement in systemic sclerosis

Beyond Rheumatology 2019; 1 (1) : e253
DOI: 10.53238_20195_253

• Newer
• 1
• …
• 3
• 4
• 5
• 6
• 7
• 8